BARCELONA—For children with intracranial ependymoma and measurable residue after first- or second-line surgery, a hypofractionated radiotherapy boost was feasible and improved local control—in a study presented to the 3rd ESTRO Forum. Lead author Lorenza Gandola MD, from Istituto Nazionale dei Tumori in Milan, explained to Oncology Times reporter Sarah Maxwell how they found that increasing the dose of radiotherapy significantly improved survival.